MUMBAI, India, Feb. 13 -- Intellectual Property India has published a patent application (202541124412 A) filed by Saveetha Institute Of Medical And Technical Sciences, Chennai, Tamil Nadu, on Dec. 10, 2025, for 'preparation of wound healing nanogel comprising chitosan, selenium nanoparticles and tridax procumbe.'
Inventor(s) include M. Vanaja; S. Rajeshkumar; and Deepak Nallaswamy Veeraiyan.
The application for the patent was published on Feb. 13, under issue no. 07/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a wound healing gel containing chitosan, selenium nanoparticles and Tridax procumbens extract. The development of this invention mainly for medicinal application for prolonged wound suffered by diabetic patients. The nanoparticle is synthesized via green methods using plant extracts as reducing agents reduces selenite into selenium nanoparticles. This nanoparticle serves as antioxidant, antibacterial, stimulates fibroblast proliferation agent. The specific wound healing compound is isolated from Tridax procumbens extract and characterized used and added into chitosan gel formulations. This plant enhances regeneration of tissues during healing of wound. This gel is easy to apply without toxicity, and eliminating toxic reagents during gel preparations. In this invention encapsulation with chitosan improves nanoparticle stability, antimicrobial, biocompatibility and biodegradability which ensuring safe medicinal purpose. Thus, invention causes some synergistic benefits are reducing healing time."
Disclaimer: Curated by HT Syndication.
